Cheng-Chia Wu, Ph.D. - Publications

Affiliations: 
2013 Pharmacology New York Medical College, New York, NY, United States 
Area:
Medicine and Surgery, Molecular Biology, Pharmacology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Garcia V, Cheng J, Weidenhammer A, Ding Y, Wu CC, Zhang F, Gotlinger K, Falck JR, Schwartzman ML. Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS. Prostaglandins & Other Lipid Mediators. 116: 124-30. PMID 25526688 DOI: 10.1016/J.Prostaglandins.2014.12.001  0.653
2014 Wu CC, Gupta T, Garcia V, Ding Y, Schwartzman ML. 20-HETE and blood pressure regulation: clinical implications. Cardiology in Review. 22: 1-12. PMID 23584425 DOI: 10.1097/Crd.0B013E3182961659  0.6
2013 Ding Y, Wu CC, Garcia V, Dimitrova I, Weidenhammer A, Joseph G, Zhang F, Manthati VL, Falck JR, Capdevila JH, Schwartzman ML. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension. American Journal of Physiology. Renal Physiology. 305: F753-63. PMID 23825080 DOI: 10.1152/Ajprenal.00292.2013  0.595
2013 Wu CC, Mei S, Cheng J, Ding Y, Weidenhammer A, Garcia V, Zhang F, Gotlinger K, Manthati VL, Falck JR, Capdevila JH, Schwartzman ML. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. Journal of the American Society of Nephrology : Jasn. 24: 1288-96. PMID 23641057 DOI: 10.1681/Asn.2012070714  0.671
2012 Cheng J, Garcia V, Ding Y, Wu CC, Thakar K, Falck JR, Ramu E, Schwartzman ML. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1917-24. PMID 22723444 DOI: 10.1161/Atvbaha.112.248344  0.672
2012 Wu C, Liu Y, Chen J, Gotlinger KH, Ramu E, Falck JR, Schwartzman ML. Abstract LB-160: CYP4F isoform expression and 20-HETE synthesis in prostate cancer cells are regulated by androgen and contribute to growth Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-160  0.578
2012 Liu Y, Wu C, Falck J, Schwartzman M. 100 THE ROLE OF 20-HETE IN PROSTATE CANCER-TUMOR VASCULATURE Journal of Hypertension. 30: e31. DOI: 10.1097/01.Hjh.0000419924.63828.Eb  0.477
2012 Wu C, Liu Y, Zhang F, Schwartzman M. The Role of Prostate Cancer 20-HETE in Tumor Vasculature International Journal of Radiation Oncology*Biology*Physics. 84: S667. DOI: 10.1016/J.Ijrobp.2012.07.1780  0.584
2011 Wu CC, Schwartzman ML. The role of 20-HETE in androgen-mediated hypertension. Prostaglandins & Other Lipid Mediators. 96: 45-53. PMID 21722750 DOI: 10.1016/J.Prostaglandins.2011.06.006  0.614
2011 Wu CC, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, Zhang Y, Jat JL, Falck JR, Schwartzman ML. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. Hypertension. 57: 788-94. PMID 21321301 DOI: 10.1161/Hypertensionaha.110.161570  0.688
2010 Sodhi K, Wu CC, Cheng J, Gotlinger K, Inoue K, Goli M, Falck JR, Abraham NG, Schwartzman ML. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent. Hypertension. 56: 871-8. PMID 20837888 DOI: 10.1161/Hypertensionaha.110.154559  0.673
2010 Cheng J, Wu CC, Gotlinger KH, Zhang F, Falck JR, Narsimhaswamy D, Schwartzman ML. 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling. The Journal of Pharmacology and Experimental Therapeutics. 332: 57-65. PMID 19841472 DOI: 10.1124/Jpet.109.159863  0.646
Show low-probability matches.